Arkema Quarterly Information: 3rd Quarter 2013 Results Solid Performance in 3^rd Quarter in a Less Favorable Environment Than Last Year Business Wire COLOMBES, France -- November 7, 2013 Regulatory News: Arkema (Paris:AKE): *€1,495million sales, close to 3Q’12 at constant exchange rates and scope of business *€233million EBITDA and 15.6% EBITDA margin *Gradual improvement in oil and gas and photovoltaic markets for High Performance Materials segment *Stability in Coating Solutions segment with marked improvement in volumes in North America *Industrial Specialties segment affected by more challenging market conditions in fluorogases and PMMA in Europe *Negative impact of the strengthening of the euro on the quarter’s performance *Net debt down to €1,033 million since 30^th June 2013 *Ongoing targeted growth capex in emerging regions *Emphasis on competitiveness in Europe The Board of Directors of Arkema met on 6^th November 2013 to close the Group’s consolidated accounts for 3^rd quarter 2013. At the end of the meeting, Thierry Le Hénaff, Chairman and CEO of Arkema, stated: «In 3^rd quarter Arkema achieved a solid performance in a mixed economic environment, in the continuity of 2^nd quarter. The strengthening of the euro also impacted the Group’s results. However, market conditions appeared to have stabilized, which could be a base for a gradual recovery in Europe next year. The High Performance Materials segment reported a high margin in a less supportive environment than last year. In 4^th quarter, EBITDA of this segment should be above last year as expected. Despite the increase in raw material costs, the Coating Solutions segment achieved a stable performance, sustained by strong volumes in North America. The Industrial Specialties segment continued to be affected by the weakness in fluorogases and PMMA in Europe. Arkema actively continued to implement its strategy: strengthening in emerging countries, targeted growth in the United States, innovation on sustainable development megatrends, and emphasis on competitiveness.» (In millions of euros) 3^rd quarter 3^rd quarter Variation 2012 2013 Sales 1,606 1,495 -6.9% EBITDA 266 233 -12.4% EBITDA margin 16.6% 15.6% High Performance 19.5% 18.8% Materials Industrial Specialties 19.8% 16.1% Coating Solutions 14.0% 13.8% Recurring operating 189 154 -18.5% income Non-recurring items - (37) n.a. Adjusted net income* 123 101 -17.9% Net income – Group share 116 65 -44.0% Diluted adjusted net 1.95 1.59 -18.5% income per share* (in €) * For Q3 2012, adjusted net income of continuing operations (excluding impact of the vinyl products activities divested at beginning of July 2012) THIRD QUARTER 2013 ACTIVITY Sales in 3^rd quarter 2013 stood at €1,495million, close to 3^rd quarter 2012 sales at constant scope of business and exchange rates. Volumes were up overall (+0.9%), sustained by the Coating Solutions segment which benefited from growth capex in North America in a favorably oriented market. The -2.0% price / product mix effect primarily reflected a rise in raw material costs for acrylics, a decrease in price of certain fluorogases, and a less favorable product mix in High Performance Materials. The -2.5% scope of business effect corresponded to the divestment of the tin stabilizer business. The significant translation effect (-3.4%) was related to the sharp decrease of the US dollar and the yen vs the euro. In a less favorable economic environment than last year, Arkema reported €233million EBITDA against €266million in 3^rd quarter 2012. The High Performance Materials segment achieved a good performance, albeit significantly down on 3^rd quarter 2012 which represented a very high basis of comparison, sustained at the time by strong demand in the oil and gas and the photovoltaic markets. The Coating Solutions segment confirmed its resilience despite a significant increase in the cost of raw materials. The Industrial Specialties segment was affected by challenging market conditions in fluorogases and PMMA in Europe. Finally, the strengthening of the euro relative to certain currencies, in particular the US dollar and the yen, impacted EBITDA with a -€9million translation effect together with the transaction effect for a close amount. EBITDA margin reached 15.6%. This good level reflects the strong positions which Arkema has developed in specialty chemicals. Recurring operating income stood at €154million against €189million in 3^rd quarter 2012, following deduction of €79million depreciation and amortization, slightly up on last year due to the startup of new capacities in the United States. Non-recurring items stood at -€37million. These mostly correspond to restructuring charges and write-off recorded following the announcement of the proposed shutdown of the Chauny site in France^1. Financial result stood at -€13million, close to 3^rd quarter 2012 (-€14million). Income taxes amounted to €40million, i.e. 26% of recurring operating income. This represents a significant improvement over 2^nd quarter which included €3million contribution due on the dividend paid in June 2013. It also reflects the geographic breakdown of the results, with a significant part of the Group’s results achieved in North America and a smaller part in Europe. Given the non-recurring items accounted for in the quarter, net income Group share stood at €65million against €116million in 3^rd quarter 2012. Excluding the impact of these non-recurring items, the adjusted net income stood at €101million, i.e. 6.8% of sales. ^1 The implementation of the project is subject to the legal information and consultation process involving the staff representatives SEGMENT PERFORMANCE IN 3^RD QUARTER 2013 HIGH PERFORMANCE MATERIALS Sales in the High Performance Materials segment stood at €451million against €548million in 3^rdquarter 2012. Half the drop in sales related to the divestment of the tin stabilizer business completed on 1^stOctober 2012. The oil and gas and photovoltaics markets, that are showing a slight sequential improvement, remained down against the high level of last year, impacting both volumes and prices. The translation effect was significant, accounting for -3% of sales. EBITDA stood at €85million, and EBITDA margin remained high at close to 19%. The impact of the divestment of the tin stabilizer business completed on 1^st October 2012 accounted for some €3million. INDUSTRIAL SPECIALTIES Performance of the Industrial Specialties segment in the quarter was affected by challenging market conditions in fluorogases and PMMA in Europe. Thiochemicals and hydrogen peroxide remained stable. Sales reached €461million against €496million in 3^rd quarter 2012. Volumes were stable overall in the segment, but the price effect was negative, mostly reflecting a less favorable product mix and greater competitive pressure in certain fluorogases. Furthermore, the decline of the dollar vs the euro led to a -3% translation effect. EBITDA stood at €74million and EBITDA margin at 16.1% against €98million and 19.8% respectively in 3^rd quarter 2012. In Thiochemicals, major projects are underway. In France, the Lacq industrial site started an 8-week turnaround in September with the aim to adapt the production plants to the new gas extraction scheme in Lacq. This work is intended to prolong the operation of the plants over the next 30 years. In Malaysia, the construction of a new industrial platform associated with a new bio-methionine plant set up by our partner CJ CheilJedang represents a strategic step in the development of this activity. Mechanical completion is scheduled for spring 2014 and startup of commercial production by mid-year. COATING SOLUTIONS Coating Solutions sales stood at €574million, 3% up on 3^rd quarter 2012. Volumes reported strong growth (+6%), sustained both by the development of acrylic monomers and by the improvement in the paint markets in North America and to a certain extent in Europe. Prices showed a slight increase. However, as with the other two segments, the translation effect was significant and accounted for -4% of sales. EBITDA at €79million and EBITDA margin at 13.8% were stable compared to 3^rd quarter 2012 (€78million and 14.0% respectively). The growth in volumes offset the negative impact of exchange rates and of the rise in raw material costs. Several projects are gathering momentum or about to be finalized across the Group’s acrylic chain. *In acrylic monomers in the United States, the acrylic acid capacity extension at Clear Lake (Texas) came on stream successfully, and the methyl acrylate unit, which represents the last phase of the $110million investment plan should come on stream in the next few months. *In France, on the Carling site, the new Sumitomo Seika superabsorbent plant was inaugurated in October. The commissioning of this plant consolidates the production of acrylic acid on the site. *In downstream activities, the construction of a new coating resins production plant on the Changshu site in China is being finalized. Startup is expected by the end of the year. CASH FLOW AND NET DEBT AT 30^TH SEPTEMBER 2013 In 3^rd quarter 2013, Arkema generated +€132million free cash flow^2. This includes a +€77million decrease in working capital related to the traditional seasonality of the activities. At end September, the working capital to sales ratio stood at 17.4% (17.7% at end September 2012). Capital expenditure in the quarter amounted to €97million, in line with the annual target of €500million. Net cash flow amounted to +€117million. It includes a €13million cash outflow related to the commitments made to Kem One. This amount had been booked in the Group’s accounts at end of 1^st quarter 2013. Net debt stood at €1,033million at 30^th September 2013 against €1,150million at 30^th June 2013, i.e. 44%gearing, close to last year’s level (43%). The Group confirms its objective to bring gearing down to some 40% by year-end. ^2 Cash flow from operations and investments excluding the impact of portfolio management. OTHER HIGHLIGHTS SINCE 1^ST JULY 2013 ORGANIC GROWTH On 4^th September 2013, Arkema announced the launch of the construction of production capacities for new generation 1234yf refrigerant fluorinated gases. This LGWP (Low Global Warming Potential) gas, intended for automotive air-conditioning, meets future needs and upcoming regulations in this sector. The first such unit, built in Asia for commissioning in 2016, will help fulfil initial 1234yf requirements. A second investment would then be made in Europe to fully replace R134a, the current refrigerant gas, from 2017 onwards. On 30^th September 2013, Arkema and Saudi investment company Watan Industrial Investment signed an agreement for the construction of an organic peroxide production site in Saudi Arabia on the Al Jubail platform. This new world-scale plant, requiring an investment of some $30 million, will help meet the major expansion of petrochemicals manufacturers in the Middle East anticipated by 2020. The joint venture between Arkema and Watan Industrial Investment will be majority held by Arkema, with the latter overseeing the operational and commercial management of the site. The plant’s startup is scheduled for early 2015. INNOVATION On 17^th October 2013, Arkema officially inaugurated its first R&D center in China on the Changshu site. This research center is to provide development capacities and local support for customers in China and South-East Asia, in particular in High Performance Materials. Meanwhile, Arkema was recognized on several occasions for the quality of its research and development: *The Group was awarded the Pierre Potier 2013 prize which rewards major chemistry innovations in the field of sustainable development for its Rilsan^® HT, a polymer of renewable origin able to resist to ultra high temperatures. *Arkema also confirmed its strong investment in innovation by ranking for the third consecutive year among the Thomson Reuters «Top 100 Global Innovators». SHAREHOLDING STRUCTURE On July 3^rd 2013, the Fonds Stratégique de Participation (FSP), a mutual fund created by four major French insurance companies – BNP Paribas Cardif, CNP Assurances, Crédit Agricole Assurances through its subsidiary Predica, and Sogécap (Groupe Société Générale) – in order to support long-term investments in listed companies, announced that it now owns 6% of Arkema’s share capital. COMPETITIVENESS On 19^th September 2013, Arkema presented to its Central Works Council a project for the closure of operations at its Chauny industrial site (France)^3. Part of the Acrylics business unit, the site produces industrial chemical intermediates primarily for the manufacture of plasticized PVC, polyester resins, and alkyd resins for paint. A charge of €30million was booked in the accounts for the quarter, including €9million write-off. ^3 The implementation of the project is subject to the legal information and consultation process involving the staff representatives OUTLOOK The market conditions observed in 3^rd quarter should continue over the year-end in particular with the strengthening effect of the euro vs the dollar across the Group’s activities. For the High Performance Materials segment, as expected, demand in the oil and gas market should improve, in particular for the Filtration and Adsorption business, and should result in an improvement in performance compared to 4^th quarter 2012. The Coating Solutions segment should continue to show its resilience in a mixed geographic environment. Industrial Specialties should continue to be affected by the weakness of fluorogases and PMMA in Europe. Finally, the 4^th quarter will reflect the traditional year-end seasonality. In this context, and taking into account the strengthening of the euro, Arkema targets for the full year an EBITDA around €920million. In the medium and long term, the Group confirms its ambition to achieve by 2016 €8billion sales and a 16% EBITDA margin while maintaining gearing below 40%, and, by 2020, the Group aims to achieve €10billion sales and a 17% EBITDA margin with gearing below 40%. FINANCIAL CALENDAR 4^th March 2014 Publication of 2013 Annual Results A global chemical company and France’s leading chemicals producer, Arkema is building the future of the chemical industry every day. Deploying a responsible, innovation-based approach, we produce state-of-the-art specialty chemicals that provide customers with practical solutions to such challenges as climate change, access to drinking water, the future of energy, fossil fuel preservation and the need for lighter materials. With operations in more than 40 countries, some 14,000 employees and 10 research centers, Arkema generates annual revenue of €6.4 billion, and holds leadership positions in all its markets with a portfolio of internationally recognized brands. Disclaimer The information disclosed in this press release may contain forward-looking statements with respect to the financial conditions, results of operations, business and strategy of Arkema. Such statements are based on management’s current views and assumptions that could ultimately prove inaccurate and are subject to risk factors such as, among others, changes in raw materials prices, currency fluctuations, implementation pace of cost-reduction projects and changes in general economic and business conditions. Arkema does not assume any liability to update such forward-looking statements whether as a result of any new information or any unexpected event or otherwise. Further information on factors which could affect Arkema’s financial results is provided in the documents filed with the French Autorité des marchés financiers. Balance sheet, income statement, cash flow statement, statement of changes in shareholders’ equity and information by business segment included in this press release are extracted from the consolidated financial statements at 31 March 2013 closed by the Board of Directors of Arkema SA on 6^th November 2013. Quarterly financial information is not audited. Business segment information is presented in accordance with Arkema’s internal reporting system used by the management. The main performance indicators used are as follows: *Operating income: this includes all income and expenses of continuing operations other than financial result, equity in income of affiliates and income taxes; *Other income and expenses: these correspond to a limited number of well-identified non-recurring items of income and expense of a particularly material nature that the Group presents separately in its income statement in order to facilitate understanding of its recurring operational performance. These items of income and expense notably include: *Impairment losses in respect of property, plant and equipment and intangible assets, *Gains or losses on sale of assets, acquisition expenses, badwills and stock valuation adjustments between the fair value on the acquisition date and the replacement value, *Certain large restructuring and environmental expenses which would hamper the interpretation of recurring operating income (including substantial modifications to employee benefit plans and the effect of onerous contracts), *Certain expenses related to litigation and claims or major damages, whose nature is not directly related to ordinary operations; *Recurring operating income: this is calculated as the difference between operating income and other income and expenses as previously defined; *Adjusted net income: this corresponds to “Net income – Group share” adjusted for the “Group share” of the following items: *Other income and expenses, after taking account of the tax impact of these items, *Income and expenses from taxation of an exceptional nature, the amount of which is deemed significant, *Net income of discontinued operations; *EBITDA: this corresponds to recurring operating income increased by depreciation and amortization; *Working capital: this corresponds to the difference between inventories, accounts receivable, other receivables and prepaid expenses, income tax receivables and other current financial assets on the one hand and accounts payable, other creditors and accrued liabilities, income tax liabilities and other current financial liabilities on the other hand. These items are classified in current assets and liabilities in the consolidated balance sheet; *Capital employed: this is calculated by aggregating the net carrying amounts of intangible assets, property, plant and equipment, equity affiliate investments and loans, other investments, other non-current assets (excluding deferred tax assets) and working capital; *Net debt: this is the difference between current and non-current debt and cash and cash equivalents.^1 The implementation of the project is subject to the legal information and consultation process involving the staff representatives^2 Cash flow from operations and investments excluding the impact of portfolio management.^3 The implementation of the project is subject to the legal information and consultation process involving the staff representatives ARKEMA Financial Statements Consolidated financial statements - At the end of September 2013 CONSOLIDATED INCOME STATEMENT 3^rd End of 3^rd End of quarter September quarter September 2013 2013 2012 2012 (In millions of (non (non (non (non euros) audited) audited) audited) audited) Sales 1,495 4,687 1,606 4,948 Operating (1,205) (3,754) (1,275) (3,920) expenses Research and development (35) (111) (35) (109) expenses Selling and administrative (101) (315) (107) (321) expenses Recurring 154 507 189 598 operating income Other income and (37) (177) - (25) expenses Operating income 117 330 189 573 Equity in income 2 5 2 8 of affiliates Financial result (13) (40) (14) (39) Income taxes (40) (146) (54) (166) Net income of continuing 66 149 123 376 operations Net income of discontinued - - (7) (171) operations Net income 66 149 116 205 Of which non-controlling 1 2 - 1 interests Net income - 65 147 116 204 Group share Of which continuing 65 147 123 375 operations Of which discontinued - - (7) (171) operations Earnings per share (amount in 1.04 2.35 1.87 3.29 euros) Earnings per share of continuing 1.04 2.35 1.97 6.04 operations (amount in euros) Diluted earnings per share 1.03 2.32 1.85 3.25 (amount in euros) Diluted earnings per share of continuing 1.03 2.32 1.95 5.97 operations (amount in euros) Depreciation and (79) (233) (77) (227) amortization EBITDA 233 740 266 825 Adjusted net income of 101 322 123 397 continuing operations Adjusted net income per share of continuing 1.61 5.14 1.98 6.40 operations (amount in euros) Diluted adjusted net income per share of continuing 1.59 5.08 1.95 6.32 operations (amount in euros) CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME 3^rd End of 3^rd End of quarter September quarter September 2013 2013 2012 2012 (In millions of (non (non (non (non euros) audited) audited) audited) audited) Net income 66 149 116 205 Hedging - (2) 7 1 adjustments Other items - - - - Deffered taxes on hedging - - - - adjustments and other items Change in translation (50) (49) (28) 12 adjustments Other recyclable comprehensive income of (50) (51) (21) 13 continuing operations Actuarial gains (1) 40 1 (43) and losses Deffered taxes on actuarial - (16) - 9 gains and losses Other non-recyclable comprehensive (1) 24 1 (34) income of continuing operations Other comprehensive income of (51) (27) (20) (21) continuing operations Other comprehensive income of - - (2) (7) discontinued operations Total income and expenses recognized (51) (27) (22) (28) directly in equity Comprehensive 15 122 94 177 income Of which: non-controlling (1) - - 1 interest Comprehensive income - Group 16 122 94 176 share CONSOLIDATED BALANCE SHEET 30 September 31 December 2013 2012 (non audited) (audited) (In millions of euros) ASSETS Intangible assets, net 965 962 Property, plant and equipment, net 1,851 1,852 Equity affiliates : investments 66 71 and loans Other investments 58 36 Deferred tax assets 67 83 Other non-current assets 153 147 TOTAL NON-CURRENT ASSETS 3,160 3,151 Inventories 968 920 Accounts receivable 900 920 Other receivables and prepaid 142 147 expenses Income taxes recoverable 37 35 Other current financial assets 2 8 Cash and cash equivalents 450 360 TOTAL CURRENT ASSETS 2,499 2,390 Assets held for sale - - TOTAL ASSETS 5,659 5,541 LIABILITIES AND SHAREHOLDERS' EQUITY Share capital 629 629 Paid-in surplus and retained 1,648 1,587 earnings Treasury shares (12) (16) Translation adjustments 35 82 SHAREHOLDERS' EQUITY - GROUP SHARE 2,300 2,282 Non-controlling interests 35 29 TOTAL SHAREHOLDERS' EQUITY 2,335 2,311 Deferred tax liabilities 45 33 Provisions for pensions and other 388 432 employee benefits Other provisions and non-current 401 446 liabilities Non-current debt 1,064 1,071 TOTAL NON-CURRENT LIABILITIES 1,898 1,982 Accounts payable 672 683 Other creditors and accrued 279 318 liabilities Income taxes payable 54 56 Other current financial 2 2 liabilities Current debt 419 189 TOTAL CURRENT LIABILITIES 1,426 1,248 Liabilities associated with assets - - held for sale TOTAL LIABILITIES AND 5,659 5,541 SHAREHOLDERS' EQUITY CONSOLIDATED CASH FLOW STATEMENT End of September End of 2013 September 2012 (In millions of euros) (non audited) (non audited) Cash flow - operating activities Net income 149 205 Depreciation, amortization and 243 272 impairment of assets Provisions, valuation allowances (27) (12) and deferred taxes (Gains)/losses on sales of assets (5) (20) Undistributed affiliate equity 4 1 earnings Change in working capital (78) (143) Other changes 6 6 Cash flow from operating 292 309 activities Of which cash flow from operating activities of discontinued - (138) operations Cash flow - investing activities Intangible assets and property, (271) (321) plant, and equipment additions Change in fixed asset payables (35) (51) Acquisitions of operations, net of (11) (245) cash acquired Increase in long-term loans (24) (44) Total expenditures (341) (661) Proceeds from sale of intangible assets and property, plant and 6 14 equipment Change in fixed asset receivables - - Proceeds from sale of operations, 1 (6) net of cash sold Proceeds from sale of - - unconsolidated investments Repayment of long-term loans 17 12 Total divestitures 24 20 Cash flow from investing (317) (641) activities Of which cash flow from investing activities from discontinued - (72) operations Cash flow - financing activities Issuance (repayment) of shares and 9 35 other equity Purchase of treasury shares - (13) Dividends paid to parent company (113) (81) shareholders Dividends paid to minority - (1) shareholders Increase/ decrease in long-term (7) 232 debt Increase/ decrease in short-term 229 132 borrowings and bank overdrafts Cash flow from financing 118 304 activities Net increase/(decrease) in cash 93 (28) and cash equivalents Effect of exchange rates and (3) (5) changes in scope Cash and cash equivalents at 360 254 beginning of period Cash and cash equivalents of discontinued operations at end of - - period Cash advance granted to - - discontinued operations Cash and cash equivalents at end 450 221 of period Of which cash and cash equivalents - - of discontinued operations CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY (non audited) Shares issued Treasury shares Shareholders' Non- (In millions Paid-in Retained Translation equity - controlling Shareholders' of euros) Number Amount surplus earnings adjustments Number Amount Group interests equity share At January 1, 62,877,215 629 977 610 82 (314,034) (16) 2,282 29 2,311 2013 Cash dividend - - (113) - - - - (113) - (113) Issuance of 70,958 - 2 - - - - 2 - 2 share capital Purchase of treasury - - - - - - - - - - shares Cancellation of purchased - - - - - - - - - - treasury shares Grants of treasury - - - (4) - 87,060 4 - - - shares to employees Sale of treasury - - - - - - - - - - shares Share-based - - - 7 - - - 7 - 7 payments Other - - - - - - - - 6 6 Transactions with 70,958 - (111) 3 - 87,060 4 (104) 6 (98) shareholders Net income - - - 147 - - - 147 2 149 Total income and expense recognized - - - 22 (47) - - (25) (2) (27) directly through equity Comprehensive - - - 169 (47) - - 122 - 122 income At September 62,948,173 629 866 782 35 (226,974) (12) 2,300 35 2,335 30, 2013 INFORMATION BY BUSINESS SEGMENT (non audited) 3^rd quarter 2013 (In millions High Industrial Coating of euros) Performance Specialties Solutions Corporate Total Materials Non-Group 451 461 574 9 1,495 sales Inter segment 3 29 21 - sales Total sales 454 490 595 9 EBITDA 85 74 79 (5) 233 Depreciation and (26) (29) (24) - (79) amortization Recurring operating 59 45 55 (5) 154 income Other income (1) - (31) (5) (37) and expenses Operating 58 45 24 (10) 117 income Equity in income of 1 - - 1 2 affiliates Intangible assets and property, 18 50 23 6 97 plant and equipment additions Of which recurring 16 24 22 6 68 capex 3^rd quarter 2012 (In millions High Industrial Coating of euros) Performance Specialties Solutions Corporate Total Materials Non-Group 548 496 557 5 1,606 sales Inter segment 3 27 16 - sales Total sales 551 523 573 5 EBITDA 107 98 78 (17) 266 Depreciation and (27) (28) (21) (1) (77) amortization Recurring operating 80 70 57 (18) 189 income Other income 2 3 (2) (3) - and expenses Operating 82 73 55 (21) 189 income Equity in income of 1 - - 1 2 affiliates Intangible assets and property, 24 38 33 7 102 plant and equipment additions Of which recurring 18 21 29 8 76 capex INFORMATION BY BUSINESS SEGMENT (non audited) End of September 2013 (In millions High Industrial Coating of euros) Performance Specialties Solutions Corporate Total Materials Non-Group 1,376 1,540 1,738 33 4,687 sales Inter segment 9 81 63 - sales Total sales 1,385 1,621 1,801 33 EBITDA 248 292 240 (40) 740 Depreciation and (77) (86) (69) (1) (233) amortization Recurring operating 171 206 171 (41) 507 income Other income (8) - (36) (133) (177) and expenses Operating 163 206 135 (174) 330 income Equity in income of 1 - - 4 5 affiliates Intangible assets and property, 49 135 68 19 271 plant and equipment additions Of which recurring 43 59 66 19 187 capex End of September 2012 (In millions High Industrial Coating of euros) Performance Specialties Solutions Corporate Total Materials Non-Group 1,654 1,594 1,683 17 4,948 sales Inter segment 15 93 64 - sales Total sales 1,669 1,687 1,747 17 EBITDA 318 320 234 (47) 825 Depreciation and (80) (84) (61) (2) (227) amortization Recurring operating 238 236 173 (49) 598 income Other income (23) 7 (5) (4) (25) and expenses Operating 215 243 168 (53) 573 income Equity in income of 1 - - 7 8 affiliates Intangible assets and property, 73 101 93 15 282 plant and equipment additions Of which recurring 67 62 80 15 224 capex Contact: Arkema Investor Relations: Sophie Fouillat, +33 1 49 00 86 37 firstname.lastname@example.org or Jérôme Raphanaud, +33 1 49 00 72 07 email@example.com or Press Relations: Gilles Galinier, +33 1 49 00 70 07 firstname.lastname@example.org or Sybille Chaixm, +33 1 49 00 70 30 email@example.com
Arkema Quarterly Information: 3rd Quarter 2013 Results
Press spacebar to pause and continue. Press esc to stop.